Cancer stem cells in osteosarcoma

Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma

Patel, A. P., Tirosh, I., Trombetta, J. J., Shalek, A. K., Gillespie, S. M., Wakimoto, H., Cahill, D. P., Nahed, B. V., Curry, W. T., Martuza, R. L., et al. (2014) · Science · doi:10.1126/science.1254257 · Cited by 5,063

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

Clarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C., Jamieson, C., Jones, D. L., Visvader, J., Weissman, I. L., & Wahl, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3126 · Cited by 3,124

Tumour evolution inferred by single-cell sequencing

Navin, N., Kendall, J., Troge, J., Andrews, P., Rodgers, L., McIndoo, J., Cook, K., Stepansky, A., Levy, D., Esposito, D., et al. (2011) · Nature · doi:10.1038/nature09807 · Cited by 2,598

Cancer stem cell definitions and terminology: the devil is in the details

Valent, P., Bonnet, D. A., Maria, R. D., Lapidot, T., Copland, M., Melo, J. V., Chomienne, C., Ishikawa, F., Schuringa, J. J., Stassi, G., et al. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3368 · Cited by 720

Mechanisms of Stem Cell Self-Renewal

He, S., Nakada, D., & Morrison, S. J. (2009) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.042308.113248 · Cited by 644

Stem-Like Cells in Bone Sarcomas: Implications for Tumorigenesis

Gibbs, C. P., Kukekov, V. G., Reith, J. D., Tchigrinova, O., Suslov, O. N., Scott, E. W., Ghivizzani, S. C., Ignatova, T. N., & Steindler, D. A. (2005) · Neoplasia · doi:10.1593/neo.05394 · Cited by 492

Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization

Tirino, V., Desiderio, V., Paino, F., ROSA, A. D., Papaccio, F., Noce, M. L., Laino, L., Francesco, F. D., & Papaccio, G. (2012) · The FASEB Journal · doi:10.1096/fj.12-218222 · Cited by 391

Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency

Kovac, M., Blattmann, C., Ribi, S., Smida, J., Mueller, N. S., Engert, F., Castro-Giner, F., Weischenfeldt, J., Kovacova, M., Krieg, A., et al. (2015) · Nature Communications · doi:10.1038/ncomms9940 · Cited by 353

Detection and Characterization of CD133+ Cancer Stem Cells in Human Solid Tumours

Tirino, V., Desiderio, V., d’Aquino, R., Francesco, F. D., Pirozzi, G., Galderisi, U., Cavaliere, C., Rosa, A. D., & Papaccio, G. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003469 · Cited by 292

Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells

Kim, K., Lee, H. W., Lee, H., Kim, S. C., Seo, Y. J., Chung, W., Eum, H. H., Nam, D., Kim, J., Joo, K. M., et al. (2015) · Genome biology · doi:10.1186/s13059-015-0692-3 · Cited by 269

Evaluating Riboglow-FLIM probes for RNA sensing

Sarfraz, N., Shafik, L. K., Stickelman, Z., Shankar, U., Moscoso, E., & Braselmann, E. (2024) · RSC Chemical Biology · doi:10.1039/d3cb00197k · Cited by 7

Identification of MCM4 and PRKDC as new regulators of osteosarcoma cell dormancy based on 3D cell cultures

Jubelin, C., Muñoz-García, J., Ollivier, E., Cochonneau, D., Vallette, F. M., Heymann, M., Oliver, L., & Heymann, D. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2024.119660 · Cited by 7

[MiR-671-5p negatively regulates SMAD3 to inhibit migration and invasion of osteosarcoma cells].

Hu, Y., Liang, D., Chen, X., Chen, L., Bai, J. Y., Li, H., Yin, C., & Zhong, W. (2021) · PubMed Central · doi:10.12122/j.issn.1673-4254.2021.10.16 · Cited by 7

The Osteosarcoma Stem Cell Activity of a Gallium(III)‐Phenanthroline Complex Appended to Salicylate

Vincent, R. A., Passeri, G., Northcote‐Smith, J., Singh, K., & Suntharalingam, K. (2022) · ChemBioChem · doi:10.1002/cbic.202200532 · Cited by 7

Encapsulation and Delivery of an Osteosarcoma Stem Cell Active Gallium(III)‐Diflunisal Complex Using Polymeric Micelles

Passeri, G., Vincent, R. A., Xiao, Z., Northcote‐Smith, J., & Suntharalingam, K. (2022) · ChemMedChem · doi:10.1002/cmdc.202200599 · Cited by 7

The OSR9 Regimen: A New Augmentation Strategy for Osteosarcoma Treatment Using Nine Older Drugs from General Medicine to Inhibit Growth Drive

Kast, R. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015474 · Cited by 7

A Novel Use of Buccal Fat Pad Flap for Immediate Reconstruction of Palatal Tumor Resection Defect

Koç, O., Tüz, H. H., & Tosun, E. (2019) · Journal of Craniofacial Surgery · doi:10.1097/scs.0000000000005593 · Cited by 7

Cluster of differentiation 44 promotes osteosarcoma progression in mice lacking the tumor suppressor Merlin

Ma, J., Klemm, J., Gerardo‐Ramírez, M., Frappart, L., Castven, D., Becker, D., Zoch, A., Parent, R., Bartosch, B., Minnich, K., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33144 · Cited by 7

Expression and crucial role of long non-coding RNA FGD5-AS1 in human cancers.

Zhu, L., Shi, X., Yu, X., Wang, Z., Zhang, M., He, Y., & Guo, W. (2021) · PubMed Central · Cited by 7

Applications of Functionalized Carbon Nanotubes in Cancer Therapy and Diagnosis

Ahmad, I., Parween, T., Khandare, L. N., Tantray, A. A., & Siddiqi, W. A. (2023) · Wiley eBooks · doi:10.1002/9781119905080.ch8 · Cited by 8

Preclinical Trials of Cancer Stem Cells Targeted by Metal-Based Coordination Complexes: A Systematic Review

Bezerra, A. C. M., Baptista, L., Couto, M. N. A., & Kanashiro, M. M. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17070931 · Cited by 6

EMT-related gene classifications predict the prognosis, immune infiltration, and therapeutic response of osteosarcoma

Li, M.-P., Long, S.-P., Liu, W., Long, K., & Gao, X.-H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1419040 · Cited by 6

Enoxacin inhibits proliferation and invasion of human osteosarcoma cells and reduces bone tumour volume in a murine xenograft model

Luo, X., Liu, X., Tao, Q., Yao, C., Wang, F., Gu, Z., Li, F., Yu, X., Zhang, B., Fan, H., et al. (2020) · Oncology Letters · doi:10.3892/ol.2020.11656 · Cited by 6

Circular RNAs in childhood‐related diseases and cancers: A review

Mao, L., Guo, J., Hu, L., Li, L., Bennett, S., Xu, J., & Zou, J. (2020) · Cell Biochemistry and Function · doi:10.1002/cbf.3611 · Cited by 6

Long non-coding RNA SOX21-AS1 modulates breast cancer stem cells properties and carcinogenesis via targeting SOX2

Lu, Z.-D., Jiao, D., Qiao, J., Yang, S., & Liu, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.23593 · Cited by 6

The Clinical Significance of the Expression of FEN1 in Primary Osteosarcoma

Zhong, G., Wang, Y., Wei, H., Chen, M., Lin, H., Huang, Z., Huang, J., Wang, S., & Lin, J. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s335817 · Cited by 6

Prognostic signature and immunotherapeutic relevance of Focal adhesion signaling pathway-related genes in osteosarcoma

Wu, Z., Wang, Z., Hua, Z., Ji, Y., Ye, Q., Zhang, H., & Yan, W. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38523 · Cited by 5

NFMCLDA: Predicting miRNA-based lncRNA-disease associations by network fusion and matrix completion

Ma, Y., Shi, Y., Chen, X. '., Zhang, B., Wu, H., & Gao, J. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108403 · Cited by 5

LncRNAs as potential prognosis/diagnosis markers and factors driving drug resistance of osteosarcoma, a review

Hu, S., Xue-bing, H., Liu, G., & Wang, S. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1415722 · Cited by 5

Post-translational modifications: The potential ways for killing cancer stem cells

Han, X., Qin, H., Lu, Y., Chen, H., Yuan, Z., Zhang, Y., Yang, X., Zheng, L., & Yan, S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34015 · Cited by 5

The enhancement apoptosis of osteosarcoma mesenchymal stem cells co-cultivation with peripheral blood mononuclear cells sensitized by secretome and granulocyte macrophage colony-stimulating factor

Mahyudin, F., Yazid, H., Edward, M., Basuki, M. H., Bari, Y. A., & Rantam, F. (2020) · Journal of Advanced Pharmaceutical Technology amp Research · doi:10.4103/japtr.japtr_52_20 · Cited by 5

The origin and polarization of Macrophages and their role in the formation of the Pre-Metastatic niche in osteosarcoma

Lai, G., Zhao, X., Chen, Y., Xie, T., Su, Z., Lin, J., Chen, K., & Chen, K. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114260 · Cited by 5

SOCS1 depletion drives osteosarcoma stemness and chemoresistance by suppressing ACTN4 degradation

Feng, J., Wei, X., Chen, L., Yang, H.-Z., Li, Y., Wang, J., Liu, Y., Xu, Y., Zhao, Q.-Q., Li, P., et al. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01650-3 · Cited by 4

Construction of a novel mRNAsi-related risk model for predicting prognosis and immunotherapy response in osteosarcoma

Li, Z., Jin, C., Lu, X., Zhang, Y., Zhang, Y., Wen, J., Liu, Y., Liu, X., & Li, J. (2023) · Annals of Translational Medicine · doi:10.21037/atm-22-6011 · Cited by 4

Comprehensive Analysis Reveals Prognostic and Therapeutic Immunity-Related Biomarkers for Pediatric Metastatic Osteosarcoma

Yuan, J., & Yu, S. (2024) · Medicina · doi:10.3390/medicina60010095 · Cited by 4

Endoplasmic reticulum stress-related features predict the prognosis of osteosarcoma and reveal STC2 as a novel risk indicator for disease progression

Yu, Y., Duan, P., Chen, H., Cheng, Y., Zhang, H., Zheng, L., Yu, J., Yu, Z., Ye, X., Xu, J., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1453173 · Cited by 4

HOPMCLDA: predicting lncRNA–disease associations based on high-order proximity and matrix completion

Xie, G., Zhu, Y., Lin, Z., Sun, Y., Gu, G., Wang, W., & Chen, H. (2021) · Molecular Omics · doi:10.1039/d1mo00138h · Cited by 4

Mitochondria and Tumor Metabolic Flexibility: Mechanisms and Therapeutic Perspectives

Rovini, A. M. F., Heslop, K. A., & Maldonado, E. N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00090-6 · Cited by 5

Identification and validation of stemness-related gene signatures to predict prognosis and immune infiltration in osteosarcoma reveals a critical role for S100A13

Li, J., Chang, C., Ma, Y., Zhuang, B., Ma, Q., Wang, Y., & Ji, Y. (2025) · BMC Cancer · doi:10.1186/s12885-025-14939-7 · Cited by 3

Deciphering the interaction between osteosarcoma and mesenchymal stem cells in a 3D bone-mimetic co-culture model

Bassi, G., Saqawa, M., Apolloni, L., Díaz‐Prado, S., Ollivier, E., Levergeois, R., Sandri, M., Campodoni, E., Cochonneau, D., Panseri, S., et al. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118956 · Cited by 3

Antigen processing and presentation‐related signature‐derived BNIP3 is a novel oncogene and immunotherapy determinant in osteosarcoma based on machine learning and in vitro validation

Chen, Y., Cao, Y., Wu, S., Cao, X., Cai, T., & Hu, H. (2023) · The Journal of Gene Medicine · doi:10.1002/jgm.3586 · Cited by 3

High expression of integrin-binding sialoprotein (IBSP) is associated with poor prognosis of osteosarcoma

Ma, Y., Chen, B., Zhang, B., Zhang, C., Zhu, Q., Wang, X., Liu, Z.-G., & Liu, H. (2023) · Aging · doi:10.18632/aging.205235 · Cited by 3

SPRR1A is a potential therapeutic target for osteosarcoma: in vitro and in vivo evaluations using generated artificial osteosarcoma cancer stem cell‑like cells

Miyamoto, T., Fukase, N., Kawamoto, T., Fujiwara, S., Hara, H., Sawada, R., Nakamatsu, Y., Mifune, Y., Kakutani, K., Hoshino, Y. Y., et al. (2024) · Oncology Reports · doi:10.3892/or.2024.8857 · Cited by 3

Early detection of increased marrow adiposity with age in rats using Z‐spectral MRI at ultra‐high field (7 T)

Cai, Z., Tao, Q., Scotti, A., Yi, P., Feng, Y., & Cai, K. (2021) · NMR in Biomedicine · doi:10.1002/nbm.4633 · Cited by 3

LncRNA UCA1 accelerates osteosarcoma progression via miR-145 and Wnt/β-catenin pathway.

Guan, J., He, J., Liao, S., Wu, Z., Lin, X., Liu, B., Xiong, Q., Tan, J., Huang, C., Yuan, Z., et al. (2022) · PubMed Central · Cited by 3

Downregulation of hsa_circ_0000885 suppressed osteosarcoma metastasis and progression via regulating E2F3 expression and sponging miR-16-5p

Li, Y., Wu, Z., & Shen, J. (2022) · Regenerative Therapy · doi:10.1016/j.reth.2022.06.004 · Cited by 3

The Natural Product Secoemestrin C Inhibits Colorectal Cancer Stem Cells via p38–S100A8 Feed-Forward Regulatory Loop

Zhou, H., Chen, M., Zhao, C., Shao, R., Xu, Y., & Zhao, W. (2024) · Cells · doi:10.3390/cells13070620 · Cited by 2

CCCTC-binding factor regulates splicing factor proline and glutamine-rich to promote malignant growth of osteosarcoma

Li, D. (2025) · American Journal of Translational Research · doi:10.62347/stqk5435 · Cited by 2

Molecular and Glycosylation Pathways in Osteosarcoma: Tumor Microenvironment and Emerging Strategies Toward Personalized Oncology

Iacobescu, G. L., Corlatescu, A.-D., Costin, H. P., Spiridonica, R., Popa, M.-I.-G., & Cîrstoiu, C. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47080629 · Cited by 2

Emerging roles and therapeutic potential of non-coding RNA in osteosarcoma: a review

Chatterjee, S., Adhikary, P., & Pal, P. C. (2025) · Medical Oncology · doi:10.1007/s12032-025-03036-1 · Cited by 2

A Primary Extraskeletal Osteosarcoma of the Spleen: Rare Case Report

Pan, X., Wang, H.-L., Lin, S., Lin, J.-L., Ruan, D., Zhang, J., Chen, T., Luo, J.-W., & Fang, Z.-T. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.892943 · Cited by 2

MIR503HG Overexpression Inhibits the Malignant Behaviors of Osteosarcoma Cells by Sponging miR-103a-3p

Li, E., Zhong, S., Ma, G., Wang, Q., & Gao, Y. (2022) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukaryotgeneexpr.2022042373 · Cited by 2

Bioinformatics analysis and validation of mesenchymal stem cells related gene MT1G in osteosarcoma

Zheng, S., Cheng, X., Ke, S., Zhang, L., Wu, H., He, D., & Cheng, X. (2024) · Aging · doi:10.18632/aging.205809 · Cited by 2

m5C modification of LINC01082 inhibits osteosarcoma progression by modulating the miR-543-TNRC6A axis

Hu, Y., Wu, J., Zeng, H., Zhou, J., Gong, M., Guo, Z., Zhang, W., Zhang, N., & Zhang, H. (2025) · Translational Oncology · doi:10.1016/j.tranon.2025.102502 · Cited by 2

Organ Systems

Smith, F. (2022) · Springer eBooks · doi:10.1007/978-3-031-13388-6_8 · Cited by 2

Roles of miR-214 in bone physiology and disease

Murari, L. S. S., KRISHNAN, R. H., AKSHAYA, R. L., Saranya, I., Das, U. R., Satishkumar, S., & Selvamurugan, N. (2023) · Biocell · doi:10.32604/biocell.2023.026911 · Cited by 2

Inhibition of circ_0127646 Enhanced the Cisplatin Sensitivity in Osteosarcoma Cells via miR‐22/KAT6B Axis

Chang, M., Chen, Q., Sun, C., Shi, X., Wu, S., Zheng, L., & Zhou, X. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70381 · Cited by 1

Targeted Inhibition of NOTCH2 and Importin‐β Promotes Osteogenic Differentiation of Osteosarcoma Cells

Wei, Z., Chen, Y., Liu, G., Deng, S., Wang, Z., & Zou, F. (2025) · Drug Development Research · doi:10.1002/ddr.70158 · Cited by 1

MMP10 is highly expressed in an osteosarcoma stem cell model and predicts poor prognosis

Yoshimoto, M., Tsuji, S., Hayashida, S., Sawada, Y., Tanaka, Y., Tokumura, K., & Hinoi, E. (2026) · Gene · doi:10.1016/j.gene.2026.150030 · Cited by 1

Cancer stem cells and clonal evolution in bone sarcomas

Rodríguez, R., Hatina, J., Gambera, S., Menéndez, S. T., & García-Castro, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821666-8.00010-4 · Cited by 1

Program and Abstracts

Cidonio, G., Brancato, V., Scognamiglio, C., Marzi, M., Barbetta, A., Riminucci, M., Nicassio, F., & Ruocco, G. (2023) · Tissue Engineering Part A · doi:10.1089/ten.tea.2023.29046.abstracts · Cited by 1

A miR-30 Guided Molecular Profiling of Canine Osteosarcoma and Extraskeletal Osteosarcoma Reveals Non-Seed Regulatory Divergence

Guelfi, G., Munteanu, P., Capaccia, C., Porcellato, I., Manuali, E., Maranesi, M., & Leonardi, L. (2025) · Cells · doi:10.3390/cells14161279 · Cited by 1

Upregulated BLM and RECQL4 in Osteosarcoma: Association with Poor Prognosis, Immune Cell Infiltration, and Inhibitory Effects of Sphingosine Kinase 1 Inhibitor II/Pilaralisib

Chen, J., Situ, Y., Cai, J., Liao, W., Jiang, D., Huang, C., Zheng, J., Peng, L., & Lin, H. (2026) · ImmunoTargets and Therapy · doi:10.2147/itt.s569823 · Cited by 1

Photoresponsive Nickel(II) Complex with Enhanced Anticancer Activity: Insights into Biomolecular Interaction and Theoretical Studies

Thamilarasan, V., Batool, A., Arumugam, S., Park, Y., Jang, H. Y., Kim, J., & Sengottuvelan, N. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00108 · Cited by 1

Isolation and Characterization of Cancer Stem Cells (CSCs)

Nalini, N., & Pratima, B. J. (2020) · Springer eBooks · doi:10.1007/978-981-15-5120-8_3 · Cited by 1

MPP8 Promotes Proliferation and Restrains Apoptosis in Osteosarcoma by Regulating p38αMAPK Pathway

Li, T., Li, N., Wang, L., Li, J., & Zhang, X. (2021) · Technology in Cancer Research & Treatment · doi:10.1177/1533033821995272 · Cited by 1

A new validated method for the quantification of Doxorubicin in plasma by High Performance Liquid Chromatography (HPLC) with application in pharmacokinetic studies: quantification of Doxorubicin by HPLC in pharmacokinetic studies

Mireles, J. A. G., Lares‐Asseff, I., Fierro, I. V., Romero, L. P., Almanza-Reyes, H. E., Grijalva, J. C. Á., Vargas, R. G., & Marín, J. L. M. (2022) · South Florida Journal of Health · doi:10.46981/sfjhv3n3-008 · Cited by 1

MASM inhibits cancer stem cell-like characteristics of EpCAM+ cells via AKT/GSK3β/β-catenin signaling.

Sun, K., Shen, H., He, S., & Liu, Y. (2022) · PubMed Central · Cited by 1

Is Ancient Medical Treatment an Option for Curating Osteosarcoma Combined with Chemotherapy? A Basic Analysis of Clinic Pharmacy

Hu, J.-Y., Gao, Y.-R., Bao, Y.-Q., Zhao, J., Liu, B., Zhao, C., & Zhang, Z.-Y. (2024) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/0113862073264769231116062123 · Cited by 1

Immunohistochemistry for Cancer Stem Cell Detection: Principles and Methods

Zannini, G., Franco, R., & Marino, F. Z. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3730-2_2 · Cited by 1

Osteosarcoma Cell and Osteosarcoma Stem Cell Potent Immunogenic Bi‐Nuclear Gallium(III) Complexes

Feng, X. S., Dhandore, S., Liu, Y., Singh, K., Ortu, F., & Suntharalingam, K. (2025) · Chemistry - A European Journal · doi:10.1002/chem.202500747 · Cited by 1

Effects of Rapamycin Combined with Cisplatin on Tumor Necrosis Factor TNF-α in MG-63 Cells

Han, T., Ma, B., Hu, B., Xiang, L., & Liu, X.-W. (2020) · Cell Transplantation · doi:10.1177/0963689720926153 · Cited by 1

Mechanism of the Notch signaling pathway in enhancing the efficacy of chemotherapy drugs in osteosarcoma.

Song, Y. (2020) · PubMed · doi:10.11817/j.issn.1672-7347.2020.190147 · Cited by 1

Exosomal miRNA-21-5p derived from bone marrow mesenchymal stem cells promote osteosarcoma cell proliferation and invasion by targeting PIK3R1Preprint

Qi, J., Zhang, R., Wu, Z., & Xia, Y. (2020) · Research Square · doi:10.21203/rs.3.rs-120370/v1 · Cited by 1

A dynamic microRNA profile that tracks a chemotherapy resistance phenotype in osteosarcoma. Implications for novel therapeuticsPreprint

Lietz, C. E., Newman, E. T., Kelly, A. D., Xiang, D. H., Zhang, Z., Ramavenkat, N., Bowers, J. J., Lozano‐Calderón, S. A., Ebb, D. H., Raskin, K. A., et al. (2024) · medRxiv · doi:10.1101/2024.06.19.24309087 · Cited by 1

Liquid biopsy in bone sarcomas and identification of new biomarkers

Tellez-Gabriel, M., & Heymann, D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821666-8.00007-4

Tracking and analysis of movement at different scales

Georgopoulou, D. G. (2020) · doi:10.23889/suthesis.59732

Meet Our Editorial Board Member

Heymann, D. (2021) · Letters in Drug Design & Discovery · doi:10.2174/157018081804210402112525

Expression of stem cell biomarkers Bmi1 and KLF4 in osteosarcoma and its clinical significancePreprint

Chen, S., Wu, T., Ning, S., Wu, Z., Jin, W., & Li, P. (2022) · Research Square · doi:10.21203/rs.3.rs-1648463/v1

Development of prognosis and diagnosis model for osteosarcoma based on oxidative stress-related genesPreprint

Li, D., Ma, T., Wu, H., Sun, W. R., He, M., Song, Q., & Cui, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-1861817/v1

Asiaticoside reduces tumor angiogenesis by inhibiting prostate cancer stem cells in an acidic microenvironmentPreprint

Zhong, S., Chen, Z., Qijie, G. U. O., Huang, S., Xie, S., Huang, S., & Wang, B. (2023) · Research Square · doi:10.21203/rs.3.rs-3217499/v1

Silencing Lnc-HES1-10 Inhibits Osteosarcoma Cells Proliferation, Invasive Ability, and Metastasis

Zhu, Y., Zhang, C., Zhang, C., Chen, S., & Jin, Z. (2023) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000002770

CTCF regulates SFPQ to promote cancerous progression of osteosarcomaPreprint

仲, 新., Li, D., Zheng, Q., Mao, L., Jiang, P., & Yin, Z. (2024) · Research Square · doi:10.21203/rs.3.rs-4377293/v1

Epigenetic aspects of a putative mechanism of antitumor action of ferrocenylalkylazoles

Babin, V. N., Belousov, Y. А., & Kulikov, V. N. (2024) · Russian Chemical Bulletin · doi:10.1007/s11172-024-4397-1

Pediatric Osteosarcoma and Chondrosarcoma: Recent Advances and Future Directions in Diagnosis and Treatment

石, 明. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1541125

MEF2C is a potential prognostic biomarker for osteosarcoma

Zheng, Z., Liao, Z., Pang, L., Xu, Z., Zhu, Y., Jia, P., & Wang, Q. (2025) · Medicine · doi:10.1097/md.0000000000044313

Additional file 3 of LncRNA WAC-AS1 promotes osteosarcoma Metastasis and stemness by sponging miR-5047 to upregulate SOX2

Yang, Z., Liu, Z., Lu, W., Guo, H., Chen, J., & Zhang, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26639530

Additional file 1 of LncRNA WAC-AS1 promotes osteosarcoma Metastasis and stemness by sponging miR-5047 to upregulate SOX2

Yang, Z., Liu, Z., Lu, W., Guo, H., Chen, J., & Zhang, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24558139

Additional file 1 of KDM3A-mediated SP1 activates PFKFB4 transcription to promote aerobic glycolysis in osteosarcoma and augment tumor development

Wang, W., & Wang, B. (2022) · Figshare · doi:10.6084/m9.figshare.19802422

Additional file 5 of LncRNA WAC-AS1 promotes osteosarcoma Metastasis and stemness by sponging miR-5047 to upregulate SOX2

Yang, Z., Liu, Z., Lu, W., Guo, H., Chen, J., & Zhang, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26639536

Additional file 2 of LncRNA WAC-AS1 promotes osteosarcoma Metastasis and stemness by sponging miR-5047 to upregulate SOX2

Yang, Z., Liu, Z., Lu, W., Guo, H., Chen, J., & Zhang, Y. (2024) · Figshare · doi:10.6084/m9.figshare.24558246

Additional file 4 of LncRNA WAC-AS1 promotes osteosarcoma Metastasis and stemness by sponging miR-5047 to upregulate SOX2

Yang, Z., Liu, Z., Lu, W., Guo, H., Chen, J., & Zhang, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26639533

Additional file 7 of LncRNA WAC-AS1 promotes osteosarcoma Metastasis and stemness by sponging miR-5047 to upregulate SOX2

Yang, Z., Liu, Z., Lu, W., Guo, H., Chen, J., & Zhang, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26639542

Additional file 6 of LncRNA WAC-AS1 promotes osteosarcoma Metastasis and stemness by sponging miR-5047 to upregulate SOX2

Yang, Z., Liu, Z., Lu, W., Guo, H., Chen, J., & Zhang, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26639539

Additional file 1 of Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategy

Alcalá, S., Villarino, L., Ruiz-Cañas, L., Couceiro, J. R., Martínez‐Calvo, M., Palencia‐Campos, A., Navarro, D., Cabezas‐Sainz, P., Rodríguez-Arabaolaza, I., Barreal, A. C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25097312

PCAT7 Enhances Doxorubicin Resistance of Osteosarcoma by Modulating TGF-β Signalling

Fang, B., Chen, Y., Li, Z., Sun, H., & Wei, S. L. (2025) · Folia Biologica · doi:10.14712/fb2025.0003

Isoforsythiaside Impedes the Viability, Motility and Microfilament Assembly in Osteosarcoma and Breast Cancer Cells via Targeting DAAM1

Zhou, J., Guo, H., Wan, M., Xue, N., Yan, T., Zhu, Y., Hu, F., & Zhang, A. (2026) · Natural Product Communications · doi:10.1177/1934578x261418401

Dual-Responsive Micelles Co-delivering All-Trans Retinoic Acid and Paclitaxel for Enhanced Eradication of Osteosarcoma Stem Cells

Chen, Z., Chen, J., Liu, S., Zhou, X., Zhang, Y., Jiang, Y., Liu, X., Zhang, Y., Pu, X., & Zhang, H. (2026) · ACS Omega · doi:10.1021/acsomega.5c13216

The ITGB2‐COPS3‐SOX2 Axis and SOX2 Liquid‐Liquid Phase Separation: Dual Mechanisms Governing Osteosarcoma Stemness

Guo, L., Zhao, Z., Wang, W., Niu, J., Wang, B., Lin, Y., Guo, W., & Yan, T. (2026) · Advanced Science · doi:10.1002/advs.202520913

FAM162A Promotes Osteosarcoma Progression Via Activating HIF‐1α to Enhance Glycolysis

Zhang, J., Liu, Z., Fan, L., Cao, R., Miao, Z., Guo, C., Yu, N., Yu, H., & Dang, X. (2026) · Molecular Carcinogenesis · doi:10.1002/mc.70112

Rôle de l’autophagie dans l’ostéosarcome

Camuzard, O. (2019) · theses.fr (ABES) · doi:10.70675/db9b0551zd9a2z4cf6z8dc4zdfbbe6b4e208

Evaluation of glyco-saccharides in a theranostic approach

Mazza, M. (2021) · doi:10.70675/11dd35fcz8433z4ab2za779z8ba4f5c7a5a2

Étude de nouvelles fonctions moléculaires et cellulaires de l'Hexokinase 2 dans le cancer

Watzky, M. (2023) · theses.fr (ABES) · doi:10.70675/73163a81z2c2bz4e11zaba1z8dc110d9c697

Single-cell and longitudinal transcriptomics-guided engineering of FZD1-targeting precision nanotherapy against osteosarcoma cancer stem cells

Chen, Z., Li, Z., Yu, W., Huang, H., Chen, J., Jiang, Y., Zhou, X., Zhong, L., Zhuo, H., Jia, Y., et al. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.07.009

A gallium(III)-polypyridyl complex bearing chrysin with anti-osteosarcoma stem cell activity

Feng, X. S., Gordon, M., Ren, H., Ortu, F., & Suntharalingam, K. (2026) · Canadian Journal of Chemistry · doi:10.1139/cjc-2026-0111

Nuclear localized p70S6K maintain cancer stem-like properties by modulating RPA3 activity in osteosarcoma

Zhou, J., Li, B., Gao, Q., Ye, Z., Zeng, X., Zhou, Y., Wang, Z., Zou, L., Zheng, Y., Wang, J., et al. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112804

Molecular biology of microRNA-515 during tumor progression

Moghbeli, M., & Attar, M. (2026) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2026.100209

Prospects for the involvement of cancer stem cells in the pathogenesis of osteosarcoma

Izadpanah, S., Shabani, P., Aghebati‐Maleki, A., Baghbanzadeh, A., Fotouhi, A., Bisadi, A., Maleki, L. A., & Baradaran, B. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29344 · Cited by 31

Research on cancer stem cells in osteosarcoma: current status, controversy and comment

Zhou, Z., & Xiao, J. (2018) · Zhonghua guke zazhi · doi:10.3760/cma.j.issn.0253-2352.2018.18.006

Cancer stem cells in osteosarcoma: Recent progress and perspective

Liu, B., Ma, W., Jha, R. K., & Gurung, K. (2011) · Acta Oncologica · doi:10.3109/0284186x.2011.584553 · Cited by 55

Targeting the osteosarcoma cancer stem cell

Siclari, V. A., & Qin, L. (2010) · Journal of Orthopaedic Surgery and Research · doi:10.1186/1749-799x-5-78 · Cited by 198

Biological evidence of cancer stem-like cells and recurrent disease in osteosarcoma

Jubelin, C., Muñoz-García, J., Cochonneau, D., Moranton, E., Heymann, M., & Heymann, D. (2022) · Cancer Drug Resistance · doi:10.20517/cdr.2021.130 · Cited by 21